FORT LAUDERDALE, Fla., Nov. 13 /PRNewswire-FirstCall/ -- Imaging Diagnostic Systems, Inc., (OTC Bulletin Board: IMDS) a pioneer in laser optical breast cancer imaging systems, announced that the Company's exclusive distributor in Italy, CTLM Italia, exhibited CTLM system results from universities in Italy and other international sites at the 4th Attualita in Senologia in Florence, Italy, October 29th-31st.
IMDS expects Italy to be one of its major European markets following early interest in the CT Laser Mammography (CTLM(R)) adjunctive solution to breast cancer detection. IMDS has several clinical research programs underway in Italy.
The meeting, which emphasized a multidisciplinary approach to managing breast cancer cases, featured scientific courses, symposia, and presentations, along with the technical exhibition. Sponsors included: Scuola Italiana di Senologia; Societa Italiana di Senologia; Gruppo Italiano Screening Mammografico; Societa Italiana di Radiologia Medica; Forza Operativa Nazionale sul Carcinoma Mammario; Europa Donna - Forum Italiano O.N.L.U.S.; and the European School of Oncology. Approximately 1400 physicians attended.
About Imaging Diagnostic Systems, Inc.
Imaging Diagnostic Systems, Inc. has developed a revolutionary new
imaging device to aid in the detection and management of breast cancer. The
CTLM(R) system is a breast imaging system that utilizes patented continuous
wave laser technology and computer algorithms to create 3-D images of the
breast. The procedure is non-invasive, painless, and does not expose the
patient to ionizing radiation or painful breast compression. CT Laser
Mammography (CTLM(R)) is designed to be used in conjunction with
mammography. It reveals information about blood distribution in the breast
and may visualize the process of angiogenesis
|SOURCE Imaging Diagnostic Systems, Inc.|
Copyright©2007 PR Newswire.
All rights reserved